CAAS Capital Management’s Science Strategic Acquisition Corp. Alpha Class A Common Stock SSAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-41,172
Closed -$406K 1067
2022
Q3
$406K Hold
41,172
0.02% 545
2022
Q2
$404K Hold
41,172
0.02% 577
2022
Q1
$404K Buy
+41,172
New +$402K 0.02% 414

CAAS Capital Management's SSAA Position: Q4 2022 in Review

CAAS Capital Management sold out of Science Strategic Acquisition Corp. Alpha Class A Common Stock (SSAA) in Q4 2022, closing a stake of 41,172 shares — an estimated $406K sold.

CAAS Capital Management first reported a position in SSAA in Q1 2022 and held it in 3 quarters. The position peaked at $406K in Q3 2022. 0 funds tracked by Wall St. Rank hold SSAA as of Q4 2022.

  • CAAS Capital Management reported no remaining Science Strategic Acquisition Corp. Alpha Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • CAAS Capital Management sold 41,172 Science Strategic Acquisition Corp. Alpha Class A Common Stock shares in Q4 2022, an estimated $406K.
  • CAAS Capital Management first reported a position in Science Strategic Acquisition Corp. Alpha Class A Common Stock in Q1 2022 and held it in 3 quarters.
  • CAAS Capital Management's Science Strategic Acquisition Corp. Alpha Class A Common Stock position peaked at $406K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Class A Common Stock as of Q4 2022.

Based on CAAS Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.